1. Mass spectrometry and proteome analysis to identify SARS-CoV-2 protein from COVID-19 patient swab samples
- Author
-
Arghya Banerjee, Medha Gayathri J Pai, Avinash Singh, Mehar Un Nissa, and Sanjeeva Srivastava
- Subjects
Health Sciences ,Clinical Protocol ,Protein Biochemistry ,Proteomics ,Mass Spectrometry ,Science (General) ,Q1-390 - Abstract
Summary: With new emerging SARS-CoV-2 strains and their increased pathogenicity, diagnosis has become more challenging. Molecular diagnosis often involves the use of nasopharyngeal swabs and subsequent real-time PCR-based tests. Although this test is the gold standard, it has several limitations; therefore, more complementary assays are required. This protocol describes how to identify SARS-CoV-2 protein from patients' nasopharyngeal swab samples. We first introduce the approach of label-free quantitative proteomics. We then detail target verification by triple quadrupole mass spectrometry (MS)-based targeted proteomics.For complete details on the use and execution of this profile, please refer to Bankar et al. (2021).
- Published
- 2022
- Full Text
- View/download PDF